These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 30148858)

  • 1. Choroidal vascularity changes in idiopathic central serous chorioretinopathy after half-fluence photodynamic therapy.
    Ma DJ; Park UC; Kim ET; Yu HG
    PLoS One; 2018; 13(8):e0202930. PubMed ID: 30148858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. En face choroidal vascular feature imaging in acute and chronic central serous chorioretinopathy using swept source optical coherence tomography.
    Lee WJ; Lee JW; Park SH; Lee BR
    Br J Ophthalmol; 2017 May; 101(5):580-586. PubMed ID: 27485721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUBFOVEAL CHOROIDAL THICKNESS AND VASCULAR DIAMETER IN ACTIVE AND RESOLVED CENTRAL SEROUS CHORIORETINOPATHY.
    Chung YR; Kim JW; Choi SY; Park SW; Kim JH; Lee K
    Retina; 2018 Jan; 38(1):102-107. PubMed ID: 28106708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choroidal Haller's and Sattler's layer thickness measurement using 3-dimensional 1060-nm optical coherence tomography.
    Esmaeelpour M; Kajic V; Zabihian B; Othara R; Ansari-Shahrezaei S; Kellner L; Krebs I; Nemetz S; Kraus MF; Hornegger J; Fujimoto JG; Drexler W; Binder S
    PLoS One; 2014; 9(6):e99690. PubMed ID: 24911446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular and structural alterations of the choroid evaluated by optical coherence tomography angiography and optical coherence tomography after half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Demirel S; Özcan G; Yanık Ö; Batıoğlu F; Özmert E
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):905-912. PubMed ID: 30617579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical coherent tomographic angiographic pattern of the deep choroidal layer and choriocapillaris after photodynamic therapy for central serous chorioretinopathy.
    Chan SY; Pan CT; Wang Q; Shi XH; Jonas JB; Wei WB
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1365-1372. PubMed ID: 31037490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. En face swept-source optical coherence tomography in neovascular age-related macular degeneration.
    Flores-Moreno I; Arias-Barquet L; Rubio-Caso MJ; Ruiz-Moreno JM; Duker JS; Caminal JM
    Br J Ophthalmol; 2015 Sep; 99(9):1260-7. PubMed ID: 25722493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choroid, Haller's, and Sattler's layer thickness in intermediate age-related macular degeneration with and without fellow neovascular eyes.
    Esmaeelpour M; Ansari-Shahrezaei S; Glittenberg C; Nemetz S; Kraus MF; Hornegger J; Fujimoto JG; Drexler W; Binder S
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5074-80. PubMed ID: 25052997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early choriocapillaris changes after half-fluence photodynamic therapy in chronic central serous chorioretinopathy evaluated by optical coherence tomography angiography: Preliminary results.
    Demircan A; Yesilkaya C; Alkin Z
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():375-378. PubMed ID: 29409857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.
    Ferrara D; Mohler KJ; Waheed N; Adhi M; Liu JJ; Grulkowski I; Kraus MF; Baumal C; Hornegger J; Fujimoto JG; Duker JS
    Ophthalmology; 2014 Mar; 121(3):719-26. PubMed ID: 24289918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-Term Choriocapillaris Changes in Patients with Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy.
    Nassisi M; Lavia C; Alovisi C; Musso L; Eandi CM
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in Choroidal Vascularity Index of Haller's layer in diabetic eyes precedes retinopathy.
    Foo VHX; Gupta P; Nguyen QD; Chong CCY; Agrawal R; Cheng CY; Yanagi Y
    BMJ Open Diabetes Res Care; 2020 Sep; 8(1):. PubMed ID: 32912848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of macular choroid in normal-tension glaucoma: a swept-source optical coherence tomography study.
    Wang YM; Hui VWK; Shi J; Wong MOM; Chan PP; Chan N; Lai I; Cheung CY; Tham CC
    Acta Ophthalmol; 2021 Dec; 99(8):e1421-e1429. PubMed ID: 33675169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping diurnal changes in choroidal, Haller's and Sattler's layer thickness using 3-dimensional 1060-nm optical coherence tomography.
    Gabriel M; Esmaeelpour M; Shams-Mafi F; Hermann B; Zabihian B; Drexler W; Binder S; Ansari-Shahrezaei S
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1957-1963. PubMed ID: 28702696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choroidal Haller's and Sattler's Layers Thickness in Normal Indian Eyes.
    Roy R; Saurabh K; Vyas C; Deshmukh K; Sharma P; Chandrasekharan DP; Bansal A
    Middle East Afr J Ophthalmol; 2018; 25(1):19-24. PubMed ID: 29899646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analyses of diameter and running pattern of choroidal vessels in central serous chorioretinopathy by en face images.
    Shiihara H; Sonoda S; Terasaki H; Kakiuchi N; Yamashita T; Uchino E; Murao F; Sano H; Mitamura Y; Sakamoto T
    Sci Rep; 2020 Jun; 10(1):9591. PubMed ID: 32533066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of choriocapillaris using optical coherence tomography and optical coherence tomography angiography in patients with central serous chorioretinopathy after half-dose photodynamic therapy.
    Yang HS; Kang TG; Park H; Heo JS; Park J; Lee KS; Choi S
    PLoS One; 2020; 15(1):e0227718. PubMed ID: 31929582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography angiography quantification of choriocapillaris blood-flow after half-fluence photodynamic therapy for chronic central serous chorioretinopathy.
    Le HM; Mrejen S; Sibilia L; Cohen SY
    Graefes Arch Clin Exp Ophthalmol; 2022 Aug; 260(8):2483-2490. PubMed ID: 35348843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy.
    Izumi T; Koizumi H; Maruko I; Takahashi Y; Sonoda S; Sakamoto T; Iida T
    Br J Ophthalmol; 2017 Apr; 101(4):433-437. PubMed ID: 27388248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy.
    Razavi S; Souied EH; Cavallero E; Weber M; Querques G
    Am J Ophthalmol; 2014 Apr; 157(4):852-60. PubMed ID: 24412124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.